Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Docetaxel/Cisplatin for Advanced Thymic Carcinoma
NCT01312324Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Feb 2007
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin in thymic carcinoma (TC), sponsored by Samsung Medical Center. Started Feb 2007; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
thymic carcinoma (TC)
Beyond the preview
Go deeper on NCT01312324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312324.